Related references
Note: Only part of the references are listed.Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
Kenichiro Enooku et al.
SCIENTIFIC REPORTS (2019)
The hedgehog pathway in nonalcoholic fatty liver disease
Mariana Verdelho Machado et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity
Naoto Fujiwara et al.
GUT (2018)
Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas
Jean-Charles Nault et al.
HEPATOLOGY (2018)
Development and Verification of an RNA Sequencing (RNA-Seq) Assay for the Detection of Gene Fusions in Tumors
Jennifer L. Winter et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Human Hepatocellular Carcinomas With a Periportal Phenotype Have the Lowest Potential for Early Recurrence After Curative Resection
Romain Desert et al.
HEPATOLOGY (2017)
Molecular classification of hepatocellular adenoma in clinical practice
Jean-Charles Nault et al.
JOURNAL OF HEPATOLOGY (2017)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
Single-cell spatial reconstruction reveals global division of labour in the mammalian liver
Keren Bahar Halpern et al.
NATURE (2017)
Pathogenesis of Nonalcoholic Steatohepatitis
Mariana Verdelho Machado et al.
GASTROENTEROLOGY (2016)
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse
Anthony W. H. Chan et al.
HISTOPATHOLOGY (2016)
Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States From 2004 to 2009
Zobair M. Younossi et al.
HEPATOLOGY (2015)
Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study
Matthew M. Yeh et al.
HUMAN PATHOLOGY (2015)
β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study
Sumiyo Ando et al.
VIRCHOWS ARCHIV (2015)
Sexual dimorphisms in zonal gene expression in mouse liver
Kosuke Saito et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
NAFLD, NASH and liver cancer
Gregory A. Michelotti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
Yan Wang et al.
CANCER CELL (2012)
The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis
Marcela Salomao et al.
HUMAN PATHOLOGY (2012)
Pathologic Criteria for Nonalcoholic Steatohepatitis: Interprotocol Agreement and Ability to Predict Liver-Related Mortality
Zobair M. Younossi et al.
HEPATOLOGY (2011)
Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway
Yotaro Kudo et al.
JOURNAL OF HEPATOLOGY (2011)
Steatohepatitic Hepatocellular Carcinoma (SH-HCC) A Distinctive Histological Variant of HCC in Hepatitis C Virus-related Cirrhosis With Associated NAFLD/NASH
Marcela Salomao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Adjusting batch effects in microarray expression data using empirical Bayes methods
W. Evan Johnson et al.
BIOSTATISTICS (2007)
Apc tumor suppressor gene is the zonation-keeper of mouse liver
Samira Benhamouche et al.
DEVELOPMENTAL CELL (2006)
Hedgehog signaling maintains resident hepatic progenitors throughout life
JK Sicklick et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
A Cadoret et al.
ONCOGENE (2002)
Share Paper
